← Company directoryNASDAQ · SEC EDGAR
argenx SE
ARGXA primary-source company identity page built for fast discovery, filing verification and consistent financial research.
SHARE PRICE · INDICATIVE——
A recent price could not be verified. Check the exchange before trading.
ANALYSIS ROUTE
Four checks before any decision
Business model
Understand how the company earns and where demand originates.
Revenue and margin
Compare equivalent periods; separate growth from profitability.
Debt and cash flow
Test balance-sheet resilience and cash conversion.
Valuation and risk
Use sector peers, scenarios and explicit risk limits.
Company calendar
argenx Q3 2026 results
Third-quarter financial results and business update. Sales, research spending and the immunology company's cash position are in focus.
argenx ↗argenx Q3 2026 results call
Management will discuss third-quarter results and business developments. The audio webcast is available through investor relations.
argenx ↗argenx full-year 2026 results
Company-scheduled full-year 2026 financial results and fourth-quarter business update. Sales, research spending and cash position are in focus.
argenx ↗More NASDAQ records
Alphabetically adjacent directory records for faster navigation; this is not a peer or valuation classification.
ARCLWARC Group Acquisition I Corp - WarrantsNASDAQ · SEC→ARCTArcturus Therapeutics Holdings Inc.NASDAQ · SEC→ARDXArdelyx, Inc.NASDAQ · SEC→ARECAmerican Resources CorporationNASDAQ · SEC→ARHSArhaus, Inc.NASDAQ · SEC→ARKOARKO Corp.NASDAQ · SEC→ARKRArk Restaurants Corp.NASDAQ · SEC→ARLPAlliance Resource Partners, L.P. - Common Units Representing Limited Partnership InterestsNASDAQ · SEC→
DATA STATUS
Open official filings ↗Checking SEC financial statements
A dash means standardized data is unavailable. Always check the filing period, currency and accounting scope.